Recomendaciones de confianza, para mirar hacia un mejor mañana

Creemos que nuestra misión es educar científicamente a nuestros pacientes, ayudándoles a entender su enfermedad y a que participen activamente en el manejo de la misma; otorgándoles en todo momento las herramientas necesarias para combatirla, en forma física, psicológica y espiritual.

Blog

Annual Meeting ASCO excerpts
Posted by: Dr. H. Alejandro Preti on 06/05/2014 12:19 PM
35
The future of PD-1 and PD-L1 inhibitors in non-small cell lung cancer looks bright.
Posted by: Dr. H. Alejandro Preti on 02/03/2014 05:50 PM
34
New ALK inhibitor, ROS1 inhibitor, EGFR inhibitor
Posted by: on 08/22/2013 08:29 AM
33

News & Press Releases

20
Jul 10, 2014
Nivolumab approval in Japan
First PD1 checkpoint inhibitor to be approved in the world for the treatment of melanoma
19
Jun 29, 2014
EXTRAORDINARY RESPONDERS
EXTRAORDINARY RESPONDERS AND BASKET TRIAL DESIGN
18
Jun 2, 2014
Immunotherapy of Cancer is here to stay
Immunotherapy of Cancer is here !!!
Captavi QixSuite™ - Hosted Marketing Automation Software ©